Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H12N2O2.ClH.H2O |
Molecular Weight | 282.723 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O.Cl.OC(=O)\C=C\C1=CC=C(CN2C=CN=C2)C=C1
InChI
InChIKey=OWIZTYOMGVTSDP-TXOOBNKBSA-N
InChI=1S/C13H12N2O2.ClH.H2O/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15;;/h1-8,10H,9H2,(H,16,17);1H;1H2/b6-5+;;
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P24557|||Q8IUN1|||Q9HD82 Gene ID: 6916.0 Gene Symbol: TBXAS1 Target Organism: Homo sapiens (Human) Sources: http://www.ncbi.nlm.nih.gov/pubmed/14720071 |
11.0 nM [IC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | DOMENAN Approved UseUnknown |
|||
Primary | XANBON Approved UseCerebral vasospasm and ischaemia following surgical management of subarachnoid haemorrhage. |
Sample Use Guides
1 tablet (200 mg of the active ingredient) at a time, twice a day after breakfast and before bedtime (for asthma). Intravenous infusion of 80mg, twice a day, solute in 500ml normal saline or 5% glucose solution (cerebral vasospasm).
Route of Administration:
Other
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
100000177063
Created by
admin on Sat Dec 16 05:12:42 GMT 2023 , Edited by admin on Sat Dec 16 05:12:42 GMT 2023
|
PRIMARY | |||
|
DTXSID30232877
Created by
admin on Sat Dec 16 05:12:42 GMT 2023 , Edited by admin on Sat Dec 16 05:12:42 GMT 2023
|
PRIMARY | |||
|
83993-01-5
Created by
admin on Sat Dec 16 05:12:42 GMT 2023 , Edited by admin on Sat Dec 16 05:12:42 GMT 2023
|
GENERIC (FAMILY) | |||
|
C0I3AF4OHV
Created by
admin on Sat Dec 16 05:12:42 GMT 2023 , Edited by admin on Sat Dec 16 05:12:42 GMT 2023
|
PRIMARY | |||
|
5282439
Created by
admin on Sat Dec 16 05:12:42 GMT 2023 , Edited by admin on Sat Dec 16 05:12:42 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD